A European provider in life science
Our vision is to improve people's lives by being a leading, value-adding partner in life scienceYear-end Report Q4 2022
Increased organic growth in both business areasCOMMENTS BY THE CEO
AddLife's sales in the fourth quarter increased by 9 percent year-on-year. As expected, COVID-19 related sales continued to decline compared with both the fourth quarter of 2021 and the third quarter of 2022. In Labtech, the organic growth rate excluding COVID-19 was 6 percent and in Medtech 5 percent. Organic growth excluding COVID-19 for the Group was 6 percent, a clear improvement compared with the previous quarter.
Our business areas
In the Medtech business area, the subsidiaries offer products and services in the field of medical technology, as well as assistive equipment for use in homecare. Medtech’s offering mainly focuses on public funded health care, homecare and social care in Europe.Read more
The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. Customers are hospitals, research laboratories, pharmaceutical companies, and food industry groups in Europe.Read more
Join the AddLife group
Do you have a life science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.
News from our subsidiaries
Great news for our O’Flynn Medical team who have been shortlisted for Green Small Organisation of the Year at the Green Awards. The Green Awards recognise the extraordinary contribution and commitment that companies now make towards growing a greener future in Ireland today.
Spectrum Ophthalmics launches a brand-new range of Dry Eye Solutions, enhancing its comprehensive portfolio.
Eidskog municipality has invested into welfare technology solutions and services with an exciting new agreement with Hepro AS.
In 2023, we are so proud to continue to support the people of Ukraine in their time of need.
Sustainability for AddLife
Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in life science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.